WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Reaches New 1-Year High – Here’s What Happened

Shares of WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) hit a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $14.68 and last traded at $14.68, with a volume of 628 shares traded. The stock had previously closed at $13.95.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

WuXi Biologics (Cayman) Trading Down 2.4%

The stock has a fifty day moving average of $12.50 and a 200-day moving average of $10.07.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.

Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.